---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-050432"
form_type: "8-K"
ticker: "BMRA"
cik: "0000073290"
company_name: "BIOMERICA INC"
filed_at: "2024-12-17T23:59:59+00:00"
generated_at: "2026-05-29T02:38:51.825872+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Biomerica shareholders approve reverse stock split authorization and 2024 Stock Incentive Plan

## Summary
- All five director nominees elected with overwhelming support; broker non-votes 5.5M.
- Say-on-pay passed with 4.6M for vs 275K against; auditor Haskell & White ratified.
- 2024 Stock Incentive Plan approved (4.2M for, 730K against); 5.5M broker non-votes.
- Reverse stock split authorization approved 9.8M for, 558K against; no broker non-votes.
- Authorized share increase passed 9.6M for; adjournment proposal also approved.

## SEC filing metadata
- accession: 0001493152-24-050432
- form_type: 8-K
- ticker: BMRA
- cik: 0000073290
- company_name: BIOMERICA INC
- filed_at: 2024-12-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/73290/000149315224050432/0001493152-24-050432-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/73290/000149315224050432/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-050432
- JSON: https://secwatch.observer/filing/0001493152-24-050432.json
- Plain text: https://secwatch.observer/filing/0001493152-24-050432.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.